Development of a transmission model for dengue virus

Virology Journal

Volumn 10, Issue , 2013, Pages

  Christofferson, Rebecca C ^a   McCracken, Michael K ^a   Johnson, Ann Marie ^a   Chisenhall, Daniel M ^a   Mores, Christopher N ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Arbovirus; Dengue; Mouse; Transmission

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS 2; DISEASE COURSE; INSECT BITE; MOSQUITO; MOUSE; NONHUMAN; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALIA; ARBOVIRUS; DENGUE VIRUS; MUS; VERTEBRATA;

EID: 84876708472     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-127     Document Type: Article

References (57)

1. Fact Sheet No. 117: Dengue and severe dengue. WHO, 2012 [cited December 8, 2012]; Available from: http://www.who.int/mediacentre/factsheets/fs117/en/
2. Dengue: twenty-five years since reemergence in Brazil. Teixeira MG, Costa Mda C, Barreto F, Barreto ML, Cad Saude Publica 2009 25 Suppl 1 7 S18 19287868
3. Climate change, population immunity, and hyperendemicity in the transmission threshold of dengue. Oki M, Yamamoto T, PLoS One 2012 7 48258 10.1371/journal.pone.0048258 23144746
4. Dynamic epidemiological models for dengue transmission: a systematic review of structural approaches. Andraud M, Hens N, Marais C, Beutels P, PLoS One 2012 7 49085 10.1371/journal.pone.0049085 23139836
5. Climatic factors influencing dengue cases in Dhaka city: a model for dengue prediction. Karim MN, Munshi SU, Anwar N, Alam MS, Indian J Med Res 2012 136 32 39 22885261
6. The dengue situation in Africa. Were F, Paediatr Int Child Health 2012 32 Suppl 1 18 21 22668445
7. Imunocompetent mice model for dengue virus infection. Goncalves D, de Queiroz Prado R, Almeida Xavier E, Cristina de Oliveira N, da Matta Guedes PM, da Silva JS, Moraes Figueiredo LT, Aquino VH, Scientific World Journal 2012 2012 525947 22666132
8. Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-beta in cultured hepatoma cells. Liang Z, Wu S, Li Y, He L, Wu M, Jiang L, Feng L, Zhang P, Huang X, PLoS One 2011 6 23346 10.1371/journal.pone.0023346 21829730
9. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. Perry ST, Buck MD, Lada SM, Schindler C, Shresta S, PLoS Pathog 2011 7 1001297 10.1371/journal.ppat.1001297 21379341
10. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, Liu DX, PLoS Negl Trop Dis 2011 5 926 10.1371/journal.pntd.0000926 21245912
11. Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Souza DG, Fagundes CT, Sousa LP, Amaral FA, Souza RS, Souza AL, Kroon EG, Sachs D, Cunha FQ, Bukin E, Proc Natl Acad Sci USA 2009 106 14138 14143 10.1073/pnas.0906467106 19666557
12. A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-gamma in host resistance to infection. Costa VV, Fagundes CT, Valadao DF, Cisalpino D, Dias AC, Silveira KD, Kangussu LM, Avila TV, Bonfim MR, Bonaventura D, PLoS Negl Trop Dis 2012 6 1663 10.1371/journal.pntd.0001663 22666512
13. IFN-gamma production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. Fagundes CT, Costa VV, Cisalpino D, Amaral FA, Souza PR, Souza RS, Ryffel B, Vieira LQ, Silva TA, Atrasheuskaya A, PLoS Negl Trop Dis 2011 5 1449 10.1371/journal.pntd.0001449 22206036
14. Viruses and interferon: a fight for supremacy. Katze MG, He Y, Gale M Jr, Nat Rev Immunol 2002 2 675 687 10.1038/nri888 12209136 (Pubitemid 37328725)
15. The interferon response circuit: induction and suppression by pathogenic viruses. Haller O, Kochs G, Weber F, Virology 2006 344 119 130 10.1016/j.virol.2005.09.024 16364743 (Pubitemid 41814456)
16. Dengue virus inhibits the production of type I interferon in primary human dendritic cells. Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A, J Virol 2010 84 4845 4850 10.1128/JVI.02514-09 20164230
17. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E, J Virol 2004 78 2701 2710 10.1128/JVI.78.6.2701-2710.2004 14990690 (Pubitemid 38314329)
18. Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. Orozco S, Schmid MA, Parameswaran P, Lachica R, Henn MR, Beatty R, Harris E, J Gen Virol 2012 93 2152 2157 10.1099/vir.0.045088-0 22815273
19. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, Zhang X, Birk A, Chang J, Shi PY, J Virol 2010 84 8332 8341 10.1128/JVI.02199-09 20534863
20. Subversion of interferon by dengue virus. Munoz-Jordan JL, Curr Top Microbiol Immunol 2010 338 35 44 10.1007/978-3-642-02215-9-3 19802576
21. Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. Liu P, Woda M, Ennis FA, Libraty DH, J Infect Dis 2009 200 191 201 10.1086/599795 19530939
22. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M, J Infect Dis 2009 200 1261 1270 10.1086/605847 19754307
23. Subcutaneous infection with non-mouse adapted Dengue virus D2Y98P strain induces systemic vascular leakage in AG129 mice. Tan GK, Ng JK, Lim AH, Yeo KP, Angeli V, Alonso S, Ann Acad Med Singapore 2011 40 523 532 22294063
24. Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. Stein DA, Huang CY, Silengo S, Amantana A, Crumley S, Blouch RE, Iversen PL, Kinney RM, J Antimicrob Chemother 2008 62 555 565 10.1093/jac/dkn221 18567576
25. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. Tan GK, Ng JK, Trasti SL, Schul W, Yip G, Alonso S, PLoS Negl Trop Dis 2010 4 672 10.1371/journal.pntd.0000672 20436920
26. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. Zompi S, Santich BH, Beatty PR, Harris E, J Immunol 2012 188 404 416 10.4049/jimmunol.1102124 22131327
27. A mouse model for studying dengue virus pathogenesis and immune response. Williams KL, Zompi S, Beatty PR, Harris E, Ann N Y Acad Sci 2009 1171 Suppl 1 12 E23 19751398
28. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Kyle JL, Balsitis SJ, Zhang L, Beatty PR, Harris E, Virology 2008 380 296 303 10.1016/j.virol.2008.08.008 18774583
29. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. Kyle JL, Beatty PR, Harris E, J Infect Dis 2007 195 1808 1817 10.1086/518007 17492597 (Pubitemid 46870254)
30. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Shresta S, Kyle JL, Robert Beatty P, Harris E, Virology 2004 319 262 273 10.1016/j.virol.2003.09.048 14980486 (Pubitemid 38251267)
31. Mouse models of dengue virus infection and disease. Yauch LE, Shresta S, Antiviral Res 2008 80 87 93 10.1016/j.antiviral.2008.06.010 18619493
32. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E, PLoS Pathog 2010 6 1000790 10.1371/journal.ppat.1000790 20168989
33. Report of an NIAID workshop on dengue animal models. Cassetti MC, Durbin A, Harris E, Rico-Hesse R, Roehrig J, Rothman A, Whitehead S, Natarajan R, Laughlin C, Vaccine 2010 28 4229 4234 10.1016/j.vaccine.2010.04.045 20434551
34. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. Mota J, Rico-Hesse R, J Virol 2009 83 8638 8645 10.1128/JVI.00581-09 19535452
35. Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. Cox J, Mota J, Sukupolvi-Petty S, Diamond MS, Rico-Hesse R, J Virol 2012 86 7637 7649 10.1128/JVI.00534-12 22573866
36. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. Daffis S, Suthar MS, Szretter KJ, Gale M Jr, Diamond MS, PLoS Pathog 2009 5 1000607 10.1371/journal.ppat.1000607 19798431
37. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T, Nature 2005 434 772 777 10.1038/nature03464 15800576 (Pubitemid 44739521)
38. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T, Immunity 2000 13 539 548 10.1016/S1074-7613(00)00053-4 11070172
39. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E, J Immunol 2005 175 3946 3954 16148142 (Pubitemid 41292056)
40. Murine model for dengue virus-induced lethal disease with increased vascular permeability. Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E, J Virol 2006 80 10208 10217 10.1128/JVI.00062-06 17005698 (Pubitemid 44522614)
41. New mouse model for dengue virus vaccine testing. Johnson AJ, Roehrig JT, J Virol 1999 73 783 786 9847388 (Pubitemid 28565427)
42. Mosquito saliva causes enhancement of West Nile virus infection in mice. Styer LM, Lim PY, Louie KL, Albright RG, Kramer LD, Bernard KA, J Virol 2011 85 1517 1527 10.1128/JVI.01112-10 21147918
43. Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. Thangamani S, Higgs S, Ziegler S, Vanlandingham D, Tesh R, Wikel S, PLoS One 2010 5 12137 10.1371/journal.pone. 0012137 20711354
44. The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Schneider BS, Higgs S, Trans R Soc Trop Med Hyg 2008 102 400 408 10.1016/j.trstmh.2008.01.024 18342898
45. Potentiation of vesicular stomatitis New Jersey virus infection in mice by mosquito saliva. Limesand KH, Higgs S, Pearson LD, Beaty BJ, Parasite Immunol 2000 22 461 467 10.1046/j.1365-3024.2000.00326.x 10972853 (Pubitemid 30636387)
46. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA, J Infect Dis 1999 179 755 762 10.1086/314680 10068569 (Pubitemid 29159319)
47. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupathy R, Nagar R, Tandon R, Pacsa AS, Younis OI, Azizieh F, J Med Virol 1999 59 335 340 10.1002/(SICI)1096-9071(199911)59:3<335::AID-JMV13>3.0. CO;2-E 10502266 (Pubitemid 29468076)
48. A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. Chen RF, Yeh WT, Yang MY, Yang KD, FEMS Immunol Med Microbiol 2001 30 1 7 10.1111/j.1574-695X.2001.tb01542.x 11172984 (Pubitemid 32144997)
49. Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment. Ip PP, Liao F, J Immunol 2010 184 5705 5714 10.4049/jimmunol.0903484 20400703
50. Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, Wu-Hsieh BA, Gerard C, Luster A, Liao F, J Immunol 2006 177 1855 1863 16849497 (Pubitemid 44092524)
51. Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, Lu MY, Wu-Hsieh BA, Lin YL, Lane TE, Luster AD, Liao F, J Immunol 2006 177 3185 3192 16920957 (Pubitemid 44304270)
52. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet. Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, Rothman AL, Thomas SJ, Jarman RG, Libraty DH, Gibbons RV, Thailand. PLoS Negl Trop Dis 2011 5 975 10.1371/journal.pntd.0000975
53. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA, Am J Epidemiol 2002 156 40 51 10.1093/aje/kwf005 12076887 (Pubitemid 34680622)
54. Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. Styer LM, Kent KA, Albright RG, Bennett CJ, Kramer LD, Bernard KA, PLoS Pathog 2007 3 1262 1270 17941708 (Pubitemid 47510279)
55. Estimating the magnitude and direction of altered arbovirus transmission due to viral phenotype. Christofferson RC, Mores CN, PLoS One 2011 6 16298 10.1371/journal.pone.0016298 21298018
56. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Golde WT, Gollobin P, Rodriguez LL, Lab Anim (NY) 2005 34 39 43 (Pubitemid 44662092)
57. A method to increase efficiency in testing pooled field-collected mosquitoes. Chisenhall DM, Vitek CJ, Richards SL, Mores CN, J Am Mosq Control Assoc 2008 24 311 314 10.2987/5671.1 18666541